Paper Details

  1. Home
  2. Paper Details

Asthma and COPD medicines prescription-claims: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020).

Author: BarrettRavina, BarrettRobert

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

An interrupted time series analysis of monthly prescription claims for asthma and chronic obstructive pulmonary disease (COPD) medicines in the UK during the first wave of the COVID-19 pandemic revealed a significant decline in the use of several medications, potentially reflecting disrupted access to healthcare. This suggests an unmet medical need that requires further investigation and urgent action to ensure continuity of care for these patients.
Paper Details　
Original Abstract of the Article :
BACKGROUND: During the pandemic, there have been disruptions to how patients seek care. RESEARCH DESIGN AND METHODS: To investigate monthly prescription claims for asthma and chronic obstructive pulmonary disease (COPD) medicines during the first UK wave, interrupted time series (ITS) analysis was ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/17476348.2022.1985470

データ提供：米国国立医学図書館（NLM）

Asthma and COPD Medications: A Disruption in Care During the COVID-19 Pandemic

The COVID-19 pandemic has significantly impacted healthcare systems worldwide. This study analyzes the impact of the pandemic on prescription claims for asthma and chronic obstructive pulmonary disease (COPD) medications in England. The researchers examine monthly prescription data, using interrupted time-series analysis to identify trends in medication use during the initial wave of the pandemic. The study's findings shed light on the disruption in care experienced by patients with these respiratory conditions.

A Disruption in Care: The COVID-19 Pandemic's Impact on Respiratory Medications

This study provides a concerning picture of the disruption in care experienced by patients with asthma and COPD during the initial wave of the COVID-19 pandemic in England. The researchers observed significant declines in prescription claims for several key medications, suggesting a potential gap in access to essential treatments. This highlights the importance of addressing the challenges faced by patients with chronic respiratory conditions during pandemics and ensuring continuity of care.

Addressing the Gap: A Call for Action

This research serves as a wake-up call for healthcare systems to address the challenges faced by patients with asthma and COPD during pandemics. It underscores the importance of proactive measures to ensure continued access to essential medications, maintain continuity of care, and address potential gaps in access to healthcare services.

Dr. Camel's Conclusion

This research is a reminder that even in the face of global crises, the needs of patients with chronic conditions must not be forgotten. It's a call for vigilance and adaptability in healthcare systems to ensure that essential care is accessible to all those who need it. It's a testament to the importance of resilience and adaptability in navigating the challenges of a pandemic.

Date :
  1. Date Completed 2021-12-13
  2. Date Revised 2021-12-14
Further Info :

Pubmed ID

34555287

DOI: Digital Object Identifier

10.1080/17476348.2022.1985470

Related Literature

Article Analysis
・Effects of beclomethasone oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.